SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 17.22 |
| Enterprise Value ($M) | -31.83 |
| Book Value ($M) | 14.27 |
| Book Value / Share | 0.24 |
| Price / Book | 1.21 |
| NCAV ($M) | 10.89 |
| NCAV / Share | 0.19 |
| Price / NCAV | 1.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.62 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -1.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.37 |
| Current Ratio | 3.37 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 49.05 |
| Assets | 52.42 |
| Liabilities | 38.16 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 11.00 |
| Operating Income | -73.94 |
| Net Income | -69.78 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted Distributed | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -71.94 |
| Cash from Investing | 0.00 |
| Cash from Financing | 9.51 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | OPOKA INVESTMENT FUND Co | 6.10 | ||
| 13G | Highbridge Capital Management Llc | 9.90 | ||
| 13G/A | Short Jay M Phd | 6.60 | 11.78 | |
| 13G/A | Millennium Management Llc | 1.90 | -54.63 | |
| 13G/A | Tang Capital Management Llc | 1.80 | ||
| 13D/A | Soleus Private Equity Fund I, L.P. | 2.56 | -53.26 | |
| 13G/A | BlackRock, Inc. | 1.60 | -72.55 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 22,388 | 148,698 | 15.06 | |
| 87,233 | 255,916 | 34.09 | |
| 181,199 | 555,589 | 32.61 | |
| 118,202 | 367,556 | 32.16 | |
| 106,256 | 582,453 | 18.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVDL – Avadel Pharmaceuticals plc | AVTE – Aerovate Therapeutics, Inc. |
| AXSM – Axsome Therapeutics, Inc. | BHST – BioHarvest Sciences Inc. |
| BTMD – biote Corp. |
Financial data and stock pages provided by
Fintel.io